Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01346319 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males.
A Phase 1 study of Hypogonadal Males, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT01346319: Completed Phase 1 study of Hypogonadal Males, sponsored by Abbott.
NCT01346319 is a Phase 1 study of Hypogonadal Males that has completed, run by Abbott. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01346319, a Phase 1 study of Hypogonadal Males, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
Phase 1 Dose Escalating Study of the safety, tolerability and pharmacokinetics of testosterone in hypogonadal males.
Primary Outcome
Blood sample results for testosterone
Conditions Studied
Interventions
- DRUG placebo
- DRUG ABT-SLV361
Study Locations (1)
Florida
- Site Reference ID/Investigator# 51964 - Fort Myers
Trial Details
| Field | Value |
|---|---|
| Start Date | 2011-04 |
| Est. Completion | 2011-09 |
| Phase | Phase 1 |
What the finished NCT01346319 record still lists
NCT01346319 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Hypogonadal Males appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01346319 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01346319 about?
NCT01346319 is a clinical study titled "Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males.". Phase 1 Dose Escalating Study of the safety, tolerability and pharmacokinetics of testosterone in hypogonadal males.
What is the current status of trial NCT01346319?
This trial is currently completed. It is a Phase 1 study. The study started on 2011-04. Estimated completion is 2011-09.
What conditions does trial NCT01346319 study?
This clinical trial studies the following conditions: Hypogonadal Males.
What interventions are being tested in trial NCT01346319?
The interventions under investigation include: placebo (DRUG), ABT-SLV361 (DRUG).
Who is sponsoring clinical trial NCT01346319?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01346319 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypogonadal Males
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia